Investigating the health risks of emerging water contaminants
Emerging Water Contaminants: Investigating and Mitigating Exposures and Health Risks
This study is looking into how a chemical called 1,4-dioxane, which can be found in drinking water and might be linked to liver cancer, interacts with other harmful substances, and it aims to help keep our water safe and protect our health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10868583 on NIH RePORTER |
What this research studies
This research focuses on understanding the health risks associated with emerging water contaminants, particularly 1,4-dioxane, which is found in drinking water and classified as a possible human carcinogen. The project aims to evaluate how this contaminant interacts with other harmful substances in water and its potential contribution to rising liver cancer rates. By developing biomarkers for exposure and biological effects, the research seeks to improve risk assessments and inform public health standards. The approach includes both laboratory studies and community engagement to address environmental health concerns.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living near Superfund sites or areas with known contamination of drinking water supplies.
Not a fit: Patients who do not reside in contaminated areas or who have no exposure to the studied water contaminants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of water contaminants, ultimately reducing health risks for affected populations.
How similar studies have performed: Previous research has shown success in identifying health risks associated with other water contaminants, suggesting that this approach could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Vasiliou, Vasilis — Yale University
- Study coordinator: Vasiliou, Vasilis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.